6 trials - PACT - PTT - PAIS - L-CAD - RECIFE - LAMIL
All chronical situations: 14 trials - MEGA - PACT - ALLHAT - PROSPER - GISSI Prevenzione - LIPID - CAIUS - CARE - KAPS - PLAC I - PLAC II - REGRESS - WOSCOPS - PMSG
Diabetic patients : 7 trials - PROVE IT TIMI 22 (diabetic sub group) - ALLHAT-LLT (diabetic sub group) - PROSPER diabetic (sub group) - GISSI P (diabetic sub group) - CARE (diabetic sub group) - LIPID (diabetic sub group) - WOSCOPS (diabetic sub group)
Elderly: 5 trials - PROSPER - LIPID (elderly sub group) - CARE (elderly subgroup) - PLAC I (elderly sub group) - REGRESS (elderly subgroup)
High risk patients with or without LDL cholesterol elevation: 4 trials - ALLHAT - PROSPER - REGRESS - PMSG
Hypertensive patients: 1 trials - ALLHAT
Patient with related disease: 1 trials - PREVEND IT
Patients with LDL elevation and without CHD: 1 trials - WOSCOPS
Patients with other atherosclerotic localisation: 1 trials - CAIUS
Patients with prior MI or with CHD: 9 trials - PACT - PTT - PAIS - GISSI Prevenzione - L-CAD - RECIFE - LIPID - LAMIL - CARE
Primary prevention: 10 trials - MEGA - PHYLLIS - ALLHAT - FAST Fukuoka pravastatin - PROSPER (primary prevention subgroup) - KLIS - CAIUS - KAPS - WOSCOPS - PMSG
Secondary prevention: 8 trials - PACT - PROSPER - GISSI Prevenzione - LIPID - CARE - PLAC I - PLAC II - REGRESS
Women: 2 trials - MEGA (women subgroup) - ALLHAT (women subgroup)
Diabetic patients with or withour hypercholesterolemia: 7 trials - PROVE IT TIMI 22 (diabetic sub group) - ALLHAT-LLT (diabetic sub group) - PROSPER diabetic (sub group) - GISSI P (diabetic sub group) - CARE (diabetic sub group) - LIPID (diabetic sub group) - WOSCOPS (diabetic sub group)
Primary prevention: 1 trials - WOSCOPS (diabetic sub group)
Secondary prevention: 5 trials - PROVE IT TIMI 22 (diabetic sub group) - PROSPER diabetic (sub group) - GISSI P (diabetic sub group) - CARE (diabetic sub group) - LIPID (diabetic sub group)